PURPOSE: Lactobacillus arizonensis BCNU 9200 strain (deposit number: KACC 91716P) and culture medium thereof are provided to have an excellent in vivo stability, antibacterial effect against pathogens causing food poisoning, and anticancer and anti-inflammatory effect, and to decrease cholesterol. CONSTITUTION: Lactobacillus arizonensis BCNU 9200 strain (deposit number: KACC 91716P) has an antibacterial effect against pathogens causing food poisoning. The Lactobacillus arizonensis BCNU 9200 (deposit number: KACC 91716P) strain has effects of decreasing cholesterol, anticancer, or anti-inflammation. The Lactobacillus arizonensis BCNU 9200 strain (deposit number: KACC 91716P) has the resistance to acid and artificial bile and adhesion to the interior of intestine. A probiotic composition contains the Lactobacillus arizonensis BCNU 9200 (deposit number: KACC 91716P) strain having an antibacterial effect against pathogens causing food poisoning or the culture medium thereof as an active ingredient.본 발명은 신규한 LactobacillusarizonensisBCNU 9200 (수탁번호: KACC 91716P) 균주 및 이를 유효성분으로 포함하는 생균제 조성물에 관한 것이다. 본 발명에 따른 LactobacillusarizonensisBCNU 9200 (수탁번호: KACC 91716P) 균주 또는 이의 배양액은 생체 내 안정성이 우수하고, 식중독을 일으키는 병원균에 항균 효과를 가지며, 콜레스테롤 저하, 항암 및 항염증의 효과가 우수하고, 소화기관 내 저해 환경에서 생존률이 우수함으로, 생균제로 유용하게 사용될 수 있다.
